Related Experiment Videos
[Liposome-mediated gene transfer into retina]
Feng Wang1, Xin Xia, Honghui Hu
1Central Experimental Laboratory, The First People's Hospital of Shanghai, Shanghai 200080, China.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|November 2, 2002
Summary
Liposome-mediated gene transfer effectively delivers genes to retinal cells, expressing therapeutic proteins like CNTF to rescue photoreceptors. However, this method shows some retinal damage, particularly to photoreceptors.
Area of Science:
- Ophthalmology
- Gene Therapy
- Biotechnology
Context:
- Retinal gene therapy holds promise for treating inherited and acquired fundus diseases.
- Liposomes are a viable non-viral vector for gene delivery.
- Understanding vector efficiency and toxicity is crucial for clinical translation.
Purpose:
- Evaluate liposome-mediated gene transfer efficiency in retinal cells.
- Determine the duration of gene expression post-transfection.
- Assess liposome-induced retinal damage.
- Explore therapeutic potential for fundus diseases.
Summary:
- In vitro studies optimized cationic liposome to plasmid ratios for transfection.
- In vivo studies involved subretinal injection of liposome-plasmid complexes in rats.
- Green fluorescein protein (GFP) expression and retinal morphology were analyzed.
- Ciliary neurotrophic factor (CNTF) gene delivery demonstrated photoreceptor rescue in a disease model.
Impact:
- Liposomes efficiently transfer genes to retinal cells, enabling therapeutic gene expression.
- Sustained gene expression exceeding 4 weeks was observed.
- Photoreceptor degeneration and outer segment damage were noted as side effects.
- Liposome-mediated delivery of CNTF shows potential for treating retinal degenerative diseases.